concrete proposal for such a meeting during the 2013 IUPAC General Assembly in Istanbul, Turkey. The event, given the number XX in the CHEMRAWN series of conferences, was initially planned to be held in Dhaka in November 2014, but due to difficulties in raising enough support for the conference (see below), the meeting was eventually postponed until 6-9 November 2015.
The Conference
The conference, held at the Bangladesh University of Health Sciences (BUHS), Dhaka, was opened by a number of thoughtful speeches by a distinguished group headed by the Honourable Minister of Science and Technology, architect Yafes Osman, of the Government of the People's Republic of Bangladesh. These proceedings set the tone and were followed by a theme lecture delivered by Professor M. Iqbal Choudhary, the director of the International Centre of Chemical & Biological Sciences (ICCBS) at the University of Karachi, Pakistan. For more than one hour, he captivated a highly competent audience that included herbal-product manufacturers, representatives from the traditional pharma industry, scientists from the natural and social sciences, herbal practitioners, and representatives from international organizations, as well as professionals from regulatory agencies, with a thorough description of the many challenges that must be addressed and resolved before herbal medicine becomes an integrated part of the global health-care system. He elaborated on the complexity of the issues and showed how the path from a medicinal plant to a herbal medicine is filled with all sorts of hurdles, many of which are non-chemical. Therefore, the way forward is indeed multidisciplinary. The following two-and-a-half days were filled with lectures, each followed by ample time for discussion, which was filled by a number of contributions from an Conference Call active audience. The topics focused on and detailed the challenges pointed out by Dr. Choudhary. Problems related to a steady, reliable, and sustainable supply of raw materials were many, and experiences from India were very useful to know when productive measures have to be taken. In this context, traditional medicinal knowledge and other ethnopharmacological aspects are very important, as made very clear in several presentations. Another important issue, covered in detail by several lecturers, was safety. A variety of topics were discussed, including documentation by chemical analysis, new approaches to toxicological testing, adulteration, and risk assessment. A less scientific safety concern is the inaccurate and even misleading information available on the Web, which can contribute to destroying the reputation of proven, high-quality, and reliable herbal medicines.
Naturally, a part of the lecture program was devoted to recent developments in chemical isolation, chemical analysis, testing of bioactivity, and development of new in vivo and in vitro screening. A proposal to establish focal-point laboratories for chemical and biochemical analyses caught significant attention and will apparently be followed up. When properly equipped and run, and adequately engaged by the industry, such facilities could greatly contribute to the scientification of the herbal-medicine industry as a whole and certainly contribute to make safe and approved herbal medicines much more accessible.
Follow-up and Future Actions
As some of the readers will know, the CHEMRAWN committee has introduced a tool termed FAC as a precautionary instrument at all its conferences. FAC stands for Future Action Committee, which is an integrated part of any CHEMRAWN conference. Such a committee is appointed before the conference and is in session during the conference to pick up and further digest good, interesting, new, brave ideas that are put forward during the lectures, discussions, and special FAC sessions. Such a committee, with six members from six countries, was working at this conference as well, and the last session of the conference discussed a conceptual report presented by the committee. A lot of valuable feedback was received, which hopefully will become clear when papers and reports from the conference are published in due course.
A tangible outcome of the conference and all the hard work leading up to it can in fact already be noted. The fact that the preparation of CHEMRAWN XX was so successful generated a lot of support for a project, pushed forward in parallel by Professor Mosihuzzaman, to establish an International Centre for Natural Product Research (ICNPR) in Bangladesh. The plans have in principle been approved by the government and are now at the final stage of approval by the Islamic Development Bank (IDB). It is envisaged that ICNPR will start to receive funds from July of this year, and the centre will certainly be a natural candidate to become a focal-point laboratory as discussed above. Leiv K. Sydnes <leiv.sydnes@kj.uib.no> is professor in organic chemistry at the University of Bergen, Norway, the immediate past chair of the CHEMRAWN committee, and a past president of IUPAC.
Chemistry and Human Health by Thomas Perun, Division VII President
The IUPAC Chemistry and Human Health Division ( Division VII) met during the General Assembly last August in Busan, Korea. The annual meeting of the Division is an opportunity for the committee to review the progress of existing projects and to discuss possible new initiatives. Projects will usually result either in IUPAC recommendations or in technical reports and books. Division VII recognizes members for meritorious service to IUPAC and to the health sciences in general through its Emeritus Fellows Program. Up to three Emeritus Fellows are appointed each Biennium. Professor Doug Templeton and Professor Robin Ganellin were the most recently recognized. A brief review of the Division mission and organization follows.
Mission
The mission of Division VII is to promote pure and applied chemistry in the service of human health and well-being. Major aspects are the development of therapeutic drugs, the standardization of clinical laboratory methods, and the protection of humans from potential
